VLDLR and atherosclerosis: While the decreased levels of very low-density lipoprotein receptor (VLDLR), apolipoprotein B (ApoB), apovitellenin 1 (ApoVLDlII), and vitellogenin (VTGI, VTGII, and VTGIII) genes expressed in the ovary are indicative of atherosclerosis, they do not explain the disease (Zhou et al., 2014).